Abdulbaqi Al-Kawaz

Mustansiriyah University — IQ

Medicine · Health Sciences

7h-index238citations24works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(14), DNA Repair Mechanisms(13), BRCA gene mutations in cancer(13), Cancer Genomics and Diagnostics(5), Cancer-related Molecular Pathways(4)

Publications24 total

Cell division cycle 6 is an independent prognostic biomarker in breast cancer
Pathology·2024· 2 citedOpen Access
Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers
Neoplasia·2023· 4 citedOpen Access
Supplementary Figure S2 from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Tables from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Figure S2 from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Data from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Figure legends from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Materials and Methods from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Figure S1 from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Figure S1 from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Materials and Methods from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Data from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Supplementary Tables from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
Figure legends from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma <i>In Situ</i> Induces Synthetic Lethality and Chemoprevention
2023Open Access
The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS)
Breast Cancer Research and Treatment·2021· 2 citedOpen Access
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
Breast Cancer Research and Treatment·2021· 6 citedOpen Access
Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ
Modern Pathology·2019· 36 citedOpen Access
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study
Modern Pathology·2019· 23 citedOpen Access
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma <i>in situ</i>
Histopathology·2019· 31 citedOpen Access
Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
Modern Pathology·2018· 25 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Emad A. Rakha(24), Michael S. Toss(23), Andrew R. Green(23), Islam M. Miligy(21), Srinivasan Madhusudan(16), Reem Ali(15), Katia A. Mesquita(14), Claire Seedhouse(14), Sameer Mirza(14), Vimla Band(12), Kylie L. Gorringe(6), Ian O. Ellis(6), Karuna Mittal(3), Ritu Aneja(2), Omar J. Mohammed(2), Nigel P. Mongan(2), Hazem Khout(1), Mohammed A. Aleskandarany(1), Vimla Band(1), Rita Haj‐Ahmad(1)